U.S. flag An official website of the United States government
  1. Home
  2. Emergency Preparedness and Response
  3. Counterterrorism and Emerging Threats
  4. Coronavirus Disease 2019 (COVID-19)
  5. COVID-19 Frequently Asked Questions
  1. Coronavirus Disease 2019 (COVID-19)

COVID-19 Frequently Asked Questions


Español

Along with other federal, state, and local agencies and public health officials across the country, the FDA continues critical work to protect public health during the COVID-19 pandemic. Find the most recent FDA updates on our Coronavirus Disease 2019 page.

The frequently asked questions (FAQs) on this page are for a general public or consumer audience. Other audiences may want to refer to additional FAQs:

General Information 

A: Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. CDC has information on COVID-19 symptoms and caring for yourself and others. COVID-19 is a new disease, caused by a novel (or new) coronavirus that has not previously been seen in humans.


Vaccines, Biologics, Human Tissues, and Blood Products

A: The FDA regulates vaccines. Vaccines undergo a rigorous review of laboratory and clinical data to ensure the safety and effectiveness of these products. Vaccines approved for marketing may also be required to undergo additional studies to further evaluate the vaccine and often to address specific questions about the vaccine's safety, effectiveness, or possible side effects. 

There are currently no vaccines available for the prevention of COVID-19. The FDA is expediting clinical trials for vaccines by providing timely advice to and interactions with vaccine developers. The FDA is also supporting product development and scaling up of manufacturing capacity for high priority vaccines for COVID-19. Vaccine developers can find more info about the review process here.


Drugs (Medicines)

A: FDA approval of a drug means that the agency has determined, based on substantial evidence, that the drug is effective for its intended use, and that the benefits of the drug outweigh its risks when used according to the product’s approved labeling. The drug approval process takes place within a structured framework that includes collecting clinical data and submitting an application to the FDA. Learn more about the FDA’s Drug Review Process.


Medical Devices Including Tests for COVID-19

A: Yes, the FDA has authorized two different types of tests (diagnostic and antibody tests) for use during the COVID-19 emergency. Though there are currently no FDA-approved or cleared tests for COVID-19, the FDA has issued over 200 Emergency Use Authorizations (EUAs) for such tests . These EUAs allow the emergency use of tests during the COVID-19 emergency when the FDA determines certain criteria are met. These criteria include that the test may be effective at diagnosing or detecting antibodies to COVID-19 and that the known and potential benefits outweigh the known and potential risks. Read more about COVID-19 tests and find a community-based testing site.


Food Products

A: To protect public health, the FDA monitors domestic firms and the foods that they produce. The FDA also monitors imported products and foreign firms exporting to the United States. The FDA protects consumers from unsafe foods through research and methods development; inspection and sampling; and regulatory and legal action.

Animals, Pets and Animal Drug Products

A: The FDA approves and regulates animal drugs to ensure they are safe and effective. In addition, the FDA helps ensure that animal food (including pet food) is safe and truthfully labeled. The FDA has post-market authority over veterinary medical devices.

    Back to Top